DiaMedica Therapeutics Inc (DMAC)
NASDAQ
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -211.416 | -226.226 | -56.893 | -77.753 | -66.179 | -36.912 | -34.213 | -43.772 |
Return on Equity (%) | 18808.629 | -409.715 | -64.365 | -86.43 | -73.099 | -38.813 | -36.06 | -46.767 |
Return on Invested Capital (%) | 19317.04 | -465.174 | -65.078 | -95.271 | -75.651 | -39.046 | -37.195 | -51.905 |
Operating Margin (%) | N/A | N/A | -1130.8 | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | -1146.8 | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 0.011 | 0.006 | 1.424 | 0.634 | 1.388 | 1.665 | 1.204 | 1.345 |
Earnings Per Share | -0.02 | -0.033 | -0.48 | -0.887 | -0.656 | -0.514 | -0.517 | -0.511 |
Cash Per Share | 0.016 | 0.011 | 1.407 | 0.323 | 0.395 | 0.178 | 0.179 | 0.12 |
Working Capital Per Share | 0.011 | 0.005 | 1.395 | 0.626 | 1.381 | 1.661 | 1.198 | 1.341 |
Operating Profit Per Share | 0.002 | 0.003 | 0.143 | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.02 | -0.033 | -0.473 | -0.884 | -0.654 | -0.513 | -0.516 | -0.509 |
EBITDA Per Share | -0.02 | -0.033 | -0.473 | -0.884 | -0.654 | -0.513 | -0.516 | -0.509 |
Free Cash Flow Per Share | -0.02 | -0.033 | -0.475 | -0.889 | -0.654 | -0.514 | -0.515 | -0.513 |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 110.52M | 127.41M | 11.96M | 12.01M | 18.75M | 26.44M | 26.44M | 37.96M |
Year End December 30 2023 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | 26.44M | 26.44M | 26.46M | 37.95M | 37.95M | 37.96M | 37.96M | 42.69M |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 217.22M |
Price to Earnings Ratio | -11.58 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 49.44 |
Price to Book Ratio | 4.4 |
Dividend Yield | - |
Shares Outstanding | 42.76M |
Average Volume (1 week) | 317.82k |
Average Volume (1 Month) | 116.06k |
52 Week Change | 99.62% |
52 Week High | 5.25 |
52 Week Low | 2.14 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.